Central Admixture Pharmacy Services, Inc. (CAPS) is recalling 1,546 bags of PHENYLephrine (phenylephrine) added to 0.9% sodium chloride, 40 mg/250 mL (160 mcg/mL). The recall was issued because particulate matter was found in the sterile injectable medication. These compounded IV bags are prescription-only products intended for hospital and office use and were distributed nationwide.
Injecting a drug containing particulate matter can cause serious health complications, such as blood vessel blockages, inflammation, or allergic reactions, which may lead to organ damage or other life-threatening issues.
Compounded drug for IV use only. Volume and concentration exclude manufacturer's overfill.
Image 1: Label for 250 mL Excel Bag containing PHENYLephrine 40 mg added to 0.9% Sodium Chloride
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.